TY - JOUR
T1 - Lifestyle modification increases serum testosterone level and decrease central blood pressure in overweight and obese men
AU - Kumagai, Hiroshi
AU - Zempo-Miyaki, Asako
AU - Yoshikawa, Toru
AU - Tsujimoto, Takehiko
AU - Tanaka, Kiyoji
AU - Maeda, Seiji
N1 - Publisher Copyright:
©The Japan Endocrine Society.
PY - 2015
Y1 - 2015
N2 - Obesity has reached global epidemic proportions and is associated with multiple comorbidities, including cardiovascular disease. A novel predictor of cardiovascular disease is elevated central systolic blood pressure. In fact, lifestyle modifications have been shown to decrease the central systolic blood pressure in overweight and obese men. The mechanism underlying these changes has yet to be fully elucidated. Interestingly, testosterone has been found to have cardioprotective effects. Moreover, serum testosterone levels are lower in obese men than in normal weight men. However, it is still unclear whether testosterone participates in the decrease of central blood pressure in overweight and obese men following lifestyle modifications. So, the purpose of the present study was to investigate the effect of testosterone on central systolic blood pressure in overweight and obese men before and after the 12-week lifestyle modification program. Forty-four overweight and obese men completed a 12-week lifestyle modification program (aerobic exercise training and dietary modifications). For all participants, central systolic blood pressure and serum testosterone levels were measured before and after the program. After the program, central systolic blood pressure was significantly decreased while serum total testosterone levels were significantly increased in overweight and obese men. Moreover, we also found a significant negative relationship between the change in serum testosterone levels and that in central systolic blood pressure. The present study suggests that increased serum testosterone levels likely contribute to a decrease in central blood pressure in overweight and obese men.
AB - Obesity has reached global epidemic proportions and is associated with multiple comorbidities, including cardiovascular disease. A novel predictor of cardiovascular disease is elevated central systolic blood pressure. In fact, lifestyle modifications have been shown to decrease the central systolic blood pressure in overweight and obese men. The mechanism underlying these changes has yet to be fully elucidated. Interestingly, testosterone has been found to have cardioprotective effects. Moreover, serum testosterone levels are lower in obese men than in normal weight men. However, it is still unclear whether testosterone participates in the decrease of central blood pressure in overweight and obese men following lifestyle modifications. So, the purpose of the present study was to investigate the effect of testosterone on central systolic blood pressure in overweight and obese men before and after the 12-week lifestyle modification program. Forty-four overweight and obese men completed a 12-week lifestyle modification program (aerobic exercise training and dietary modifications). For all participants, central systolic blood pressure and serum testosterone levels were measured before and after the program. After the program, central systolic blood pressure was significantly decreased while serum total testosterone levels were significantly increased in overweight and obese men. Moreover, we also found a significant negative relationship between the change in serum testosterone levels and that in central systolic blood pressure. The present study suggests that increased serum testosterone levels likely contribute to a decrease in central blood pressure in overweight and obese men.
KW - Central blood pressure
KW - Lifestyle modification
KW - Obesity
KW - Testosterone
UR - http://www.scopus.com/inward/record.url?scp=84933522555&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84933522555&partnerID=8YFLogxK
U2 - 10.1507/endocrj.EJ14-0555
DO - 10.1507/endocrj.EJ14-0555
M3 - Article
C2 - 25753766
AN - SCOPUS:84933522555
SN - 0918-8959
VL - 62
SP - 423
EP - 430
JO - Endocrine Journal
JF - Endocrine Journal
IS - 5
ER -